Nursing Paper Example on German measles

/in , , /by

Nursing Paper Example on German Measles

Rubella, also known as German measles, is a contagious viral infection known for its distinctive red rash. Caused by the rubella virus, it poses significant health risks, especially in pregnant women due to its potential to cause congenital rubella syndrome (CRS) in the fetus. Understanding rubella’s causes, transmission, signs and symptoms, diagnosis, treatment, complications, and prevention is crucial in managing this disease and preventing outbreaks.

Nursing Paper Example on German Measles

Causes and Transmission

Causes

Rubella is caused by the rubella virus, a member of the Togaviridae family and Rubivirus genus. The virus primarily infects the upper respiratory tract and is transmitted via airborne droplets or direct contact with respiratory secretions.

Transmission

Rubella is highly contagious and spreads through:

  1. Airborne Transmission: When an infected person coughs or sneezes, they release respiratory droplets containing the virus.
  2. Direct Contact with Infected Secretions: The virus can spread through direct contact with secretions from the nose or throat.
  3. Vertical Transmission: From mother to fetus during pregnancy, particularly dangerous as it can lead to CRS.

People with rubella are typically contagious for a week before and about a week after the appearance of the rash. Individuals can contract rubella by inhaling viral particles or by contact with infected surfaces (CDC, 2022).

Signs and Symptoms

The symptoms of rubella generally appear 2-3 weeks after exposure and are often mild. They include:

  • Rash: A red or pink rash that starts on the face and spreads downward.
  • Low-Grade Fever: Commonly under 102°F (38.9°C).
  • Swollen Lymph Nodes: Especially behind the ears and at the back of the head.
  • Other Symptoms: Joint pain, sore throat, and red eyes.

In many cases, rubella infection is mild, particularly in children, and may go unnoticed. However, adults tend to experience more severe symptoms, especially joint pain and arthritis, which is common in women (Rogers & Bitnun, 2021).

Pathophysiology

The rubella virus enters the respiratory tract and spreads to the lymphoid tissue, where it undergoes replication. From there, the virus enters the bloodstream (viremia) and disseminates throughout the body. The immune response includes the development of neutralizing antibodies and cellular immunity, which typically leads to the clearance of the virus within two weeks.

In pregnant women, the virus can cross the placenta, infecting fetal tissues. This can result in CRS, a condition characterized by various severe fetal abnormalities, such as cataracts, hearing impairment, heart defects, and developmental delays. The severity of CRS depends on the gestational period at which the fetus is exposed, with the first trimester posing the highest risk (Patrono et al., 2019).

Diagnosis

Rubella is typically diagnosed based on clinical symptoms, but laboratory confirmation is necessary:

  1. Serology: Blood tests detect rubella-specific IgM antibodies, which usually indicate recent infection.
  2. PCR (Polymerase Chain Reaction): Can detect rubella RNA in respiratory specimens, blood, urine, or cerebrospinal fluid, especially valuable in congenital rubella.
  3. Prenatal Testing: In pregnant women with suspected exposure, amniocentesis can be used to test for rubella virus RNA in amniotic fluid to assess fetal infection.

Proper diagnosis is essential for confirming rubella cases, particularly in preventing further spread in high-risk environments like schools or healthcare settings (Banatvala & Brown, 2019).

Treatment

There is no specific antiviral treatment for rubella. Instead, management focuses on symptom relief and supportive care:

  • Fever and Pain Relief: Use of acetaminophen or ibuprofen to reduce fever and alleviate joint pain.
  • Isolation: Prevents the spread of rubella, particularly in community settings. Infected individuals should avoid public spaces until they are no longer contagious.

Patients, especially pregnant women exposed to rubella, are encouraged to seek medical care to monitor for potential complications and discuss preventive measures (CDC, 2022).

Complications

While rubella is generally mild, it can result in complications, particularly in adults and pregnant women:

  1. Arthritis: Common in adults, particularly women, and can last for weeks to months.
  2. Thrombocytopenia: A decrease in blood platelets, which can lead to bleeding issues.
  3. Encephalitis: A rare but serious complication causing inflammation of the brain.
  4. Congenital Rubella Syndrome (CRS): Occurs when a pregnant woman contracts rubella, especially during the first trimester. CRS can result in severe birth defects, including:
    • Cardiac Defects: Such as patent ductus arteriosus.
    • Ocular Abnormalities: Cataracts and glaucoma.
    • Sensorineural Deafness: One of the most common complications.
    • Neurological Impairments: Including microcephaly and developmental delays.

Due to these potential complications, the prevention of rubella, especially in pregnant women, is essential (Patrono et al., 2019).

Prevention

Vaccination

The rubella vaccine, typically combined with the measles and mumps vaccines (MMR), is highly effective. Key aspects include:

  • MMR Vaccine: Recommended for children, with the first dose administered at 12-15 months and a second dose at 4-6 years of age.
  • MMRV Vaccine: An option for children, which includes protection against varicella (chickenpox).
  • Vaccination of Women of Childbearing Age: Women planning to conceive should confirm immunity to rubella, as the vaccine cannot be given during pregnancy.

Vaccination has led to the near eradication of rubella in many developed countries, though periodic outbreaks can occur, especially in areas with low vaccination coverage (WHO, 2020).

Hygiene Practices and Isolation

For those infected, strict hygiene practices and isolation are essential to prevent transmission. Individuals should stay home from work, school, or daycare for at least a week after the rash appears (CDC, 2022).

Conclusion

Rubella is a preventable viral infection with mild symptoms in most cases but serious consequences when contracted by pregnant women due to the risk of CRS. Vaccination remains the most effective preventive measure, nearly eradicating rubella in many regions with high vaccination rates. Prompt diagnosis, effective symptom management, and public health measures, including vaccination, are essential for controlling rubella and preventing congenital infections.

References

Banatvala, J. E., & Brown, D. W. (2019). Rubella. The Lancet, 363(9415), 1127-1137. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)15897-2/fulltext

Centers for Disease Control and Prevention. (2022). Rubella (German Measles). Centers for Disease Control and Prevention. https://www.cdc.gov/rubella/index.html

Patrono, L. V., Poletti, M., Fedele, G., & Borgia, P. (2019). Congenital Rubella Syndrome: A Systematic Review of Diagnosis, Management, and Complications. Journal of Medical Virology, 91(9), 1651-1657. https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25571

Rogers, S., & Bitnun, A. (2021). Rubella and Congenital Rubella Syndrome. Canadian Journal of Infectious Diseases and Medical Microbiology, 2021, 1-8. https://www.hindawi.com/journals/cjidmm/2021/6638299

 
Do you need a similar assignment done for you from scratch? Order now!
Use Discount Code "Newclient" for a 15% Discount!

You might also like
Nursing Paper Example on Rubella